Montz Harcus Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Buy
1,653
+35
+2% +$8.16K 0.15% 59
2026
Q1
$396K Buy
1,618
+243
+18% +$56.6K 0.16% 55
2025
Q4
$285K Buy
+1,375
New +$272K 0.12% 70
2024
Q4
Sell
-1,461
Closed -$237K 78
2024
Q3
$237K Sell
1,461
-272
-16% -$43.3K 0.14% 61
2024
Q2
$253K Sell
1,733
-211
-11% -$31.4K 0.16% 52
2024
Q1
$308K Buy
1,944
+159
+9% +$25.3K 0.21% 46
2023
Q4
$280K Buy
1,785
+235
+15% +$36K 0.21% 41
2023
Q3
$241K Sell
1,550
-102
-6% -$16.8K 0.21% 44
2023
Q2
$273K Buy
1,652
+12
+0.7% +$1.94K 0.23% 43
2023
Q1
$254K Sell
1,640
-140
-8% -$22.6K 0.23% 43
2022
Q4
$314K Buy
1,780
+50
+3% +$8.63K 0.31% 37
2022
Q3
$283K Buy
1,730
+163
+10% +$27.6K 0.31% 38
2022
Q2
$278K Buy
1,567
+9
+0.6% +$1.6K 0.29% 40
2022
Q1
$276K Buy
1,558
+67
+4% +$11.4K 0.25% 41
2021
Q4
$255K Buy
+1,491
New +$244K 0.22% 40

Other funds holding JNJ

Montz Harcus Wealth Management's JNJ Position: Q2 2026 in Review

Montz Harcus Wealth Management increased its Johnson & Johnson (JNJ) stake by 2.2% in Q2 2026, buying an estimated $8.16K and bringing the position to 1,653 shares worth $420K. The position accounts for 0.15% of the portfolio, ranked #59.

Montz Harcus Wealth Management first reported a position in JNJ in Q4 2021 and has held it in 15 quarters since. 1,965 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Montz Harcus Wealth Management held 1,653 shares of Johnson & Johnson worth $420K as of Q2 2026.
  • Montz Harcus Wealth Management bought 35 Johnson & Johnson shares in Q2 2026, an estimated $8.16K.
  • Johnson & Johnson made up 0.15% of Montz Harcus Wealth Management's portfolio in Q2 2026, its #59 holding.
  • Montz Harcus Wealth Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 15 quarters since.
  • 1,965 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Montz Harcus Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.